Wells Fargo’s Eloxx Pharmaceuticals ELOX Stock Holding History
Bought
Maintained
Sold
Other funds holding ELOX
SL
Wells Fargo's ELOX Position: Q3 2026 in Review
Wells Fargo held its Eloxx Pharmaceuticals (ELOX) position steady in Q3 2026 at 126 shares worth $1.93K. The position accounts for ﹤0.01% of the portfolio, ranked #6409.
Wells Fargo first reported a position in ELOX in Q2 2026 and has held it in 2 quarters since. 20 funds tracked by Wall St. Rank hold ELOX as of Q3 2026.
- Wells Fargo held 126 shares of Eloxx Pharmaceuticals worth $1.93K as of Q3 2026.
- Wells Fargo left its Eloxx Pharmaceuticals share count unchanged in Q3 2026.
- Eloxx Pharmaceuticals made up ﹤0.01% of Wells Fargo's portfolio in Q3 2026, its #6409 holding.
- Wells Fargo first reported a position in Eloxx Pharmaceuticals in Q2 2026 and has held it in 2 quarters since.
- 20 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals as of Q3 2026.
Based on Wells Fargo's 13F filing for Q3 2026, filed 16 Nov 2026.